A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
about
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate CancerRadioisotopes in management of metastatic prostate cancerRadium-223 dichloride in clinical practice: a review.Recent advances: oncologyOutpatient therapeutic nuclear oncology.Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.Radium-223 for the treatment of castration-resistant prostate cancer.Tumor dosimetry and response for 153Sm-ethylenediamine tetramethylene phosphonic acid therapy of high-risk osteosarcoma.Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastasesTherapeutic strategies for bone metastases and their clinical sequelae in prostate cancer.Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigms.Bone-Targeted Imaging and Radionuclide Therapy in Prostate CancerA Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases.Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastasesModeling the time dependent biodistribution of Samarium-153 ethylenediamine tetramethylene phosphonate using compartmental analysis.Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone painA phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.Retrospective evaluation of bone pain palliation after samarium-153-EDTMP therapy.Sm:HAp Nanopowders Present Antibacterial Activity againstEnterococcus faecalis
P2860
Q26752785-7F513752-8D16-45C7-8CEC-2EEC194A10FAQ28068134-E29C83CE-518C-40D3-90C3-6522F5ADBD50Q30251496-6BC6DA6A-8FF5-4A5D-BBE1-9B7D7D974294Q33793871-816ED589-6E43-4569-B8D1-7B019D3EC8A0Q34244990-151D740F-0710-46F8-A7A2-A0B9B4000C49Q35057029-F18BBD78-C9CC-407A-897D-90E261CA35BDQ35653986-936C8540-0570-4CC5-98F2-70A559513FCDQ35792772-50EFB3E9-79C0-433D-A8EA-DF3FD2999CB4Q36648239-C577B122-9740-4C7D-8BB8-0A8E584CB366Q36840731-EA154935-CDE9-4F38-B653-C70AA13E9CB7Q37166534-A5A3A2DF-E2CB-427E-9A2E-47FA929CD4AEQ37390666-A2D0AFDB-F142-4D16-B477-36870CF45FDCQ37509952-6582076F-7151-4637-A831-47B243F9286EQ38004275-4D5A1495-5369-4BE5-BC3C-B98949C5A06CQ39191700-4CBAA28A-8E32-4D1F-B572-2376742B250AQ40671776-2EDA8AFE-9AB8-495A-B758-52E9276EC725Q41852414-EEC660E1-D6A6-44F8-95FE-C0D5EFDE1FAEQ45138883-2AF8FC99-EFA5-4486-8B88-10A24BAAEE17Q45227161-DE3B6D2F-B711-4FE1-A326-D0A00DF5BD39Q59059139-6E076655-C7E1-43F8-96AC-4ED07DD1FFC9
P2860
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A phase I study of samarium-15 ...... seminated skeletal metastases.
@ast
A phase I study of samarium-15 ...... seminated skeletal metastases.
@en
type
label
A phase I study of samarium-15 ...... seminated skeletal metastases.
@ast
A phase I study of samarium-15 ...... seminated skeletal metastases.
@en
prefLabel
A phase I study of samarium-15 ...... seminated skeletal metastases.
@ast
A phase I study of samarium-15 ...... seminated skeletal metastases.
@en
P2093
P1476
A phase I study of samarium-15 ...... seminated skeletal metastases.
@en
P2093
A A Martindale
E L Hetherington
J H Turner
P G Claringbold
P304
P356
10.1200/JCO.1989.7.12.1926
P407
P577
1989-12-01T00:00:00Z